Items 1 to 10 of about 314669
1. Lee EA, Shin J, Hwang EJ, Lee JW: Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007-2012. Korean J Fam Med; 2017 May;38(3):116-121

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007-2012.
  • METHODS: We included 17,765 adults (738 cancer survivors and 17,027 individuals without cancer) in this study, all of whom who were 30 years of age or older and participated in the Fourth and Fifth Korean National Health and Nutritional Examination Surveys from 2007-2012.
  • Secondary primary cancer screening of female cancer survivors needs to be planned in a comprehensive manner, with the consideration of influences beyond sociodemographic factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Can Fam Physician. 2012 Sep;58(9):980-6 [22972732.001]
  • [Cites] Curr Oncol. 2014 Oct;21(5):e670-7 [25302037.001]
  • [Cites] Cancer Causes Control. 2009 Nov;20(9):1697-703 [19688183.001]
  • [Cites] Am J Prev Med. 2005 May;28(4):351-6 [15831340.001]
  • [Cites] J Cancer Surviv. 2013 Sep;7(3):455-63 [23645522.001]
  • [Cites] Cancer. 2011 Aug 15;117(16):3850-9 [21319155.001]
  • [Cites] Cancer Causes Control. 2010 Dec;21(12):2203-12 [21052819.001]
  • [Cites] Cancer Res Treat. 2015 Apr;47(2):127-41 [25761484.001]
  • [Cites] Cancer. 2004 Oct 15;101(8):1712-9 [15386307.001]
  • [Cites] J Clin Oncol. 2008 Mar 1;26(7):1073-9 [18309941.001]
  • [Cites] Cancer Res Treat. 2016 Jan;48(1):1-10 [25943324.001]
  • [Cites] JAMA. 1994 Aug 17;272(7):530-4 [8046807.001]
  • [Cites] J Oncol Pract. 2010 Jul;6(4):174-81 [21037867.001]
  • [Cites] J Clin Oncol. 2005 Dec 1;23(34):8884-93 [16314649.001]
  • [Cites] Patient Educ Couns. 2011 Oct;85(1):74-8 [21036507.001]
  • [Cites] BMC Cancer. 2011 Jun 17;11:257 [21682886.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2020-6 [17057028.001]
  • [Cites] J Natl Cancer Inst. 2004 Sep 1;96(17):1322-30 [15339970.001]
  • [Cites] Obstet Gynecol. 2009 Apr;113(4):790-5 [19305321.001]
  • [Cites] BMC Cancer. 2012 Nov 26;12:557 [23181637.001]
  • [Cites] Int J Cancer. 2001 Jul 15;93(2):155-61 [11410860.001]
  • [Cites] J Korean Acad Nurs. 2014 Apr;44(2):139-48 [24859119.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12(1):327-33 [21517281.001]
  • [Cites] J Obstet Gynecol Neonatal Nurs. 2008 Jan-Feb;37(1):51-7 [18226157.001]
  • [Cites] Asia Pac J Public Health. 2013 Nov;25(6):476-86 [24151045.001]
  • (PMID = 28572886.001).
  • [ISSN] 2005-6443
  • [Journal-full-title] Korean journal of family medicine
  • [ISO-abbreviation] Korean J Fam Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Breast Neoplasms / Early Detection of Cancer / Survivors / Uterine Cervical Neoplasms
  •  go-up   go-down


2. Kohmoto T, Okamoto N, Naruto T, Murata C, Ouchi Y, Fujita N, Inagaki H, Satomura S, Okamoto N, Saito M, Masuda K, Kurahashi H, Imoto I: A case with concurrent duplication, triplication, and uniparental isodisomy at 1q42.12-qter supporting microhomology-mediated break-induced replication model for replicative rearrangements. Mol Cytogenet; 2017;10:15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case with concurrent duplication, triplication, and uniparental isodisomy at 1q42.12-qter supporting microhomology-mediated break-induced replication model for replicative rearrangements.
  • One-ended DNA break repair coupled with microhomology-mediated break-induced replication (MMBIR) has been recently proposed as a possible mechanism giving rise to interstitial copy number gains and distal isoUPD, although only a few cases providing supportive evidence in human congenital diseases with MCA have been documented.
  • CASE PRESENTATION: Here, we report on the chromosomal microarray (CMA)-based identification of the first known case with concurrent interstitial duplication at 1q42.12-q42.2 and triplication at 1q42.2-q43 followed by isoUPD for the remainder of chromosome 1q (at 1q43-qter).
  • In distal 1q duplication/triplication overlapping with 1q42.12-q43, variable clinical features have been reported, and our 25-year-old patient with MCA/ID presented with some of these frequently described features.
  • Further analyses including the precise mapping of breakpoint junctions within the CGR in a sequence level suggested that the CGR found in association with isoUPD in our case is a triplication with flanking duplications, characterized as a triplication with a particularly long duplication-inverted triplication-duplication (DUP-TRP/INV-DUP) structure.
  • CONCLUSIONS: To the best of our knowledge, this is the first case of CGRs + isoUPD observed in 1q and having DUP-TRP/INV-DUP structure with a long proximal duplication, which supports MMBIR-based model for genomic rearrangements.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Genet. 2009 Jul;25(7):298-307 [19560228.001]
  • [Cites] J Med Genet. 2011 Sep;48(9):635-9 [21617255.001]
  • [Cites] Cytogenet Genome Res. 2007;118(1):84-6 [17901705.001]
  • [Cites] Am J Med Genet A. 2015 Oct;167A(10):2327-33 [26061664.001]
  • [Cites] Eur J Hum Genet. 2014 Jan;22(1):79-87 [23695279.001]
  • [Cites] Am J Med Genet A. 2008 Oct 15;146A(20):2663-7 [18798309.001]
  • [Cites] BMC Evol Biol. 2015 Oct 29;15:234 [26514418.001]
  • [Cites] Curr Opin Genet Dev. 2012 Jun;22(3):211-20 [22440479.001]
  • [Cites] Am J Med Genet A. 2013 Aug;161A(8):1904-9 [23824987.001]
  • [Cites] Am J Med Genet A. 2016 Apr;170A(4):908-17 [26782913.001]
  • [Cites] Am J Med Genet A. 2003 Jul 15;120A(2):229-33 [12833404.001]
  • [Cites] Am J Med Genet A. 2009 Feb 15;149A(4):793-7 [19248177.001]
  • [Cites] Nat Genet. 2013 Nov;45(11):1319-26 [24056715.001]
  • [Cites] Eur J Hum Genet. 2015 Jan;23(1):61-6 [24713661.001]
  • [Cites] Mol Syndromol. 2016 Feb;6(6):297-303 [27022331.001]
  • [Cites] Am J Hum Genet. 2015 Apr 2;96(4):555-64 [25799105.001]
  • (PMID = 28465723.001).
  • [Journal-full-title] Molecular cytogenetics
  • [ISO-abbreviation] Mol Cytogenet
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; 1q / Breakpoint junction sequence / Chromosomal microarray / Complex genomic rearrangement / DUP-TRP/INV-DUP structure / Microhomology-mediated break-induced replication model / Template switching / Uniparental isodisomy
  •  go-up   go-down


3. Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP, European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease: Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014. Emerg Infect Dis; 2017 Mar;23(3):396-404

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014.
  • We describe the epidemiology of invasive Haemophilus influenzae disease during 2007-2014 in 12 European countries and assess overall H. influenzae disease trends by serotype and patient age.
  • Mean annual notification rate was 0.6 cases/100,000 population, with an increasing annual trend of 3.3% (95% CI 2.3% to 4.3%).
  • The notification rate was highest for patients <1 month of age (23.4 cases/100,000 population).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vaccine. 2015 Nov 17;33(46):6227-34 [26440924.001]
  • [Cites] Lancet Infect Dis. 2008 May;8(5):275-6 [18471770.001]
  • [Cites] Int J Circumpolar Health. 2016 Jan 12;75:29798 [26765260.001]
  • [Cites] Vaccine. 2011 May 17;29(22):3857-62 [21459175.001]
  • [Cites] Vaccine. 2010 May 28;28(24):4073-8 [20398617.001]
  • [Cites] Emerg Infect Dis. 2010 Mar;16(3):455-63 [20202421.001]
  • [Cites] BMC Infect Dis. 2009 Apr 20;9:45 [19379490.001]
  • [Cites] Clin Infect Dis. 2011 Dec;53(12):1230-6 [22080119.001]
  • [Cites] Lancet Infect Dis. 2014 Dec;14(12):1281-92 [25012226.001]
  • [Cites] Wkly Epidemiol Rec. 2006 Nov 24;81(47):445-52 [17124755.001]
  • [Cites] Euro Surveill. 2005 Jul 28;10(7):E050728.4 [16785672.001]
  • [Cites] Clin Microbiol Infect. 2010 Jul;16(7):948-54 [19889054.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):661-8 [20306323.001]
  • [Cites] JAMA. 2014 Mar 19;311(11):1125-32 [24643602.001]
  • [Cites] Clin Infect Dis. 2013 Dec;57(12):1715-21 [24076970.001]
  • [Cites] Clin Infect Dis. 2011 Jul 1;53(1):e1-7 [21653293.001]
  • [Cites] Pediatr Infect Dis J. 2016 Mar;35(3):e76-84 [26569188.001]
  • [Cites] Emerg Infect Dis. 2012 May;18(5):725-32 [22515912.001]
  • [Cites] Pediatrics. 1990 Apr;85(4 Pt 2):631-5 [2179852.001]
  • [Cites] Clin Infect Dis. 2015 Oct 1;61(7):1203-4 [26123935.001]
  • [Cites] Epidemiol Infect. 2013 Sep;141(9):1787-96 [23425638.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):603-10 [24154654.001]
  • [Cites] Clin Vaccine Immunol. 2012 May;19(5):766-71 [22398246.001]
  • [Cites] Lancet. 1993 Apr 3;341(8849):851-4 [8096561.001]
  • [Cites] Clin Microbiol Rev. 2000 Apr;13(2):302-17 [10756001.001]
  • [Cites] Eur J Public Health. 2008 Aug;18(4):371-5 [18424469.001]
  • [Cites] Vaccine. 2012 Jan 11;30(3):565-71 [22119925.001]
  • [Cites] Clin Infect Dis. 2015 Jun 15;60(12):1786-92 [25784720.001]
  • [Cites] Eur J Clin Microbiol. 1984 Jun;3(3):180-4 [6332016.001]
  • [Cites] PLoS One. 2015 Nov 16;10(11):e0142179 [26569613.001]
  • [Cites] J Infect Dis. 1995 Jan;171(1):93-8 [7798687.001]
  • [Cites] Clin Vaccine Immunol. 2015 May;22(5):459-66 [25787137.001]
  • [Cites] Clin Microbiol Infect. 2012 Sep;18(9):918-23 [22070637.001]
  • [Cites] J Infect. 2012 Dec;65(6):496-504 [22902945.001]
  • [Cites] PLoS One. 2014 Nov 07;9(11):e112711 [25379704.001]
  • [Cites] Clin Microbiol Infect. 2011 Nov;17(11):1638-45 [21054663.001]
  • (PMID = 28220749.001).
  • [ISSN] 1080-6059
  • [Journal-full-title] Emerging infectious diseases
  • [ISO-abbreviation] Emerging Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Europe / bacteria / coccobacillus / epidemiology / invasive Haemophilus influenzae disease / invasive disease / invasive pathogen / serotype / surveillance / temporal trends / vaccine
  •  go-up   go-down


4. Pinsker EA, Enzler AW, Hoffman MC, Call KT, Amos S, Babington-Johnson A, Okuyemi KS: A Community-Driven Implementation of the Body and Soul Program in Churches in the Twin Cities, Minnesota, 2011-2014. Prev Chronic Dis; 2017 Mar 23;14:E26

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A Community-Driven Implementation of the Body and Soul Program in Churches in the Twin Cities, Minnesota, 2011-2014.
  • The objectives of this project were to promote healthy eating among African American church members, engage African American churches in the implementation of Body and Soul (an evidenced-based program that encourages healthy eating), and implement the program in the community with minimal resources.
  • METHODS: From 2011 through 2014 we conducted a community engagement project to implement the 12-week Body and Soul program, which includes demonstrations of healthy recipes and peer counseling, in 20 churches.
  • Church coordinators (n = 11) completed a survey evaluating the program.
  • Church coordinators reported enthusiasm about Body and Soul at their church, and 10 of 11 church coordinators indicated that their pastor encouraged members to attend Body and Soul events.
  • This project demonstrated that Body and Soul can be implemented in communities with little funds or other resources.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Nutr. 2000 Jun;71(6):1503-10 [10837291.001]
  • [Cites] J Am Diet Assoc. 1990 Feb;90(2):214-20 [2303658.001]
  • [Cites] Prev Chronic Dis. 2013 Jun 20;10:E99 [23786910.001]
  • [Cites] Annu Rev Public Health. 1998;19:173-202 [9611617.001]
  • [Cites] J Natl Med Assoc. 2004 Dec;96(12):1599-605 [15622690.001]
  • [Cites] Prev Chronic Dis. 2013;10 :E33 [23489638.001]
  • [Cites] Am J Prev Med. 2004 Aug;27(2):97-105 [15261895.001]
  • [Cites] Acad Med. 1996 May;71(5):425-31 [9114857.001]
  • [Cites] Am J Public Health. 2001 Oct;91(10):1686-93 [11574336.001]
  • [Cites] Health Educ Behav. 2007 Dec;34(6):864-80 [17200096.001]
  • [Cites] Prev Med. 1993 May;22(3):373-87 [8392175.001]
  • [Cites] J Natl Med Assoc. 1984 May;76(5):477-83 [6737505.001]
  • [Cites] J Am Diet Assoc. 2004 Dec;104(12 ):1873-7 [15565084.001]
  • (PMID = 28333599.001).
  • [ISSN] 1545-1151
  • [Journal-full-title] Preventing chronic disease
  • [ISO-abbreviation] Prev Chronic Dis
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R25 CA163184; United States / NCI NIH HHS / CA / T32 CA163184
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Lavall D, Schuster P, Jacobs N, Kazakov A, Böhm M, Laufs U: Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling. J Biol Chem; 2017 May 05;292(18):7542-7553
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The expression of 11β hydroxysteroid dehydrogenase type 2 (11β-HSD2) was age-dependently up-regulated in the atria and the left ventricles of RacET mice on mRNA and protein levels.
  • Samples of human left atrial myocardium showed a positive correlation between Rac1 activity and 11β-HSD2 expression (<i>r</i> = 0.7169).
  • Both basal and phorbol 12-myristate 13-acetate (PMA)-induced NADPH oxidase activity were increased in RacET and correlated positively with 11β-HSD2 expression (<i>r</i> = 0.788 and <i>r</i> = 0.843, respectively).
  • [MeSH-major] 11-beta-Hydroxysteroid Dehydrogenase Type 2 / biosynthesis. Endomyocardial Fibrosis / enzymology. Fibroblasts / enzymology. Myocardium / enzymology. Myocytes, Cardiac / enzymology. Neuropeptides / biosynthesis. Signal Transduction. rac1 GTP-Binding Protein / biosynthesis

  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • Hazardous Substances Data Bank. (L)-Methionine .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
  • [Cites] Circulation. 2000 Nov 28;102(22):2700-6 [11094035.001]
  • [Cites] J Am Coll Cardiol. 2012 May 1;59(18):1598-603 [22538330.001]
  • [Cites] Cardiovasc Res. 2002 Mar;53(4):911-20 [11922901.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 18;101(20):7618-23 [15128949.001]
  • [Cites] N Engl J Med. 2015 Mar 19;372(12):1138-49 [25785971.001]
  • [Cites] Hypertension. 2012 Feb;59(2):500-6 [22232135.001]
  • [Cites] Mol Cell Endocrinol. 2012 Mar 24;350(2):168-86 [21820034.001]
  • [Cites] Circ Res. 1991 Dec;69(6):1476-86 [1683272.001]
  • [Cites] Lancet. 2012 Feb 18;379(9816):648-61 [22166900.001]
  • [Cites] Vitam Horm. 2000;58:121-48 [10668397.001]
  • [Cites] J Am Coll Cardiol. 2010 Feb 2;55(5):469-80 [20117462.001]
  • [Cites] J Mol Cell Cardiol. 2011 Apr;50(4):678-85 [21215756.001]
  • [Cites] J Biol Chem. 2001 Jul 27;276(30):28484-92 [11350956.001]
  • [Cites] J Am Coll Cardiol. 2015 Aug 25;66(8):943-59 [26293766.001]
  • [Cites] J Hypertens. 2012 Oct;30(10):1977-85 [22914542.001]
  • [Cites] Hypertens Res. 2011 May;34(5):584-91 [21248754.001]
  • [Cites] J Biol Chem. 2014 Mar 7;289(10):6656-68 [24469458.001]
  • [Cites] Nat Med. 2008 Dec;14(12):1370-6 [19029984.001]
  • [Cites] J Mol Cell Cardiol. 2016 Sep;98:95-102 [27423273.001]
  • [Cites] Hypertension. 2015 Feb;65(2):257-63 [25368026.001]
  • [Cites] J Clin Invest. 2000 Apr;105(7):875-86 [10749567.001]
  • [Cites] J Am Coll Cardiol. 2007 Jul 24;50(4):359-67 [17659204.001]
  • [Cites] Hypertension. 2016 Jan;67(1):99-106 [26527051.001]
  • [Cites] Cardiovasc Res. 2006 Jul 15;71(2):342-51 [16698001.001]
  • [Cites] N Engl J Med. 2016 May 5;374(18):1744-53 [27144849.001]
  • [Cites] J Clin Invest. 2011 Aug;121(8):3233-43 [21765214.001]
  • [Cites] Hypertension. 2007 May;49(5):1120-7 [17372041.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2008 Mar;17(2):174-80 [18277151.001]
  • [Cites] Eur Heart J. 2016 Jul 14;37(27):2129-200 [27206819.001]
  • [Cites] Circ Res. 2016 Mar 18;118(6):1021-40 [26987915.001]
  • [Cites] Endocrinology. 2006 Dec;147(12):5564-7 [16946012.001]
  • (PMID = 28320863.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTGF protein, human; 0 / Ctgf protein, mouse; 0 / Ctgf protein, rat; 0 / Fibronectins; 0 / Neuropeptides; 0 / RAC1 protein, human; 0 / Rac1 protein, mouse; 0 / Sulfoxides; 0 / buthionine sulfoxide; 139568-91-5 / Connective Tissue Growth Factor; 4964P6T9RB / Aldosterone; AE28F7PNPL / Methionine; EC 1.1.1.146 / 11-beta-Hydroxysteroid Dehydrogenase Type 2; EC 3.6.1.- / Rac1 protein, rat; EC 3.6.5.2 / rac1 GTP-Binding Protein; NI40JAQ945 / Tetradecanoylphorbol Acetate
  • [Keywords] NOTNLM ; 11β hydroxysteroid dehydrogenase type 2 / Rac (Rac GTPase) / Rac1 / aldosterone / connective tissue growth factor (CTGF) / fibrosis / mineralocorticoid receptor
  •  go-up   go-down


6. Zhang Y, Gong Y, Wang C, Liu W, Wang Z, Xia Z, Bu Z, Lu H, Sun Y, Zhang X, Cao Y, Yang F, Su H, Hu Y, Deng Y, Zhou B, Zhao Z, Fu Y, Kargbo D, Dafae F, Kargbo B, Kanu A, Liu L, Qian J, Guo Z: Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic. PLoS Negl Trop Dis; 2017 May;11(5):e0005622
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.
  • METHODOLOGY/PRINCIPAL FINDINGS: On September 26, 2014, China dispatched a Mobile Biosafety Level-3 Laboratory (MBSL-3 Lab) and a well-trained diagnostic team to Sierra Leone to assist in EVD diagnosis using quantitative real-time PCR, which allowed the diagnosis of suspected EVD cases in less than 4 hours from the time of sample receiving.
  • A total of 1,635 suspected EVD cases (824 positive [50.4%]) were tested from September 28 to November 11, 2014, and no member of the diagnostic team was infected with Ebola virus or other pathogens, including Lassa fever.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6 [15896665.001]
  • [Cites] J Clin Microbiol. 2001 Nov;39(11):4125-30 [11682540.001]
  • [Cites] PLoS Negl Trop Dis. 2011 May;5(5):e1183 [21629730.001]
  • [Cites] Med Sante Trop. 2015 Jul-Sep;25(3):229-33 [26446739.001]
  • [Cites] Pediatrics. 2006 May;117(5 Pt 3):S412-5 [16735275.001]
  • [Cites] Acad Emerg Med. 2015 May;22(5):616-22 [25900204.001]
  • [Cites] Emerg Infect Dis. 2003 Nov;9(11):1430-7 [14718087.001]
  • [Cites] J Virol. 2003 Sep;77(18):9733-7 [12941881.001]
  • [Cites] Lancet. 2011 Mar 5;377(9768):849-62 [21084112.001]
  • [Cites] PLoS One. 2014 Aug 20;9(8):e105401 [25141120.001]
  • [Cites] Zoonoses Public Health. 2012 Sep;59 Suppl 2:151-7 [22958259.001]
  • [Cites] Emerg Infect Dis. 2015 May;21(5):856-9 [25897646.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S28-35 [9988162.001]
  • [Cites] J Natl Med Assoc. 2005 May;97(5):648-56 [15926641.001]
  • [Cites] PLoS One. 2013 Jul 02;8(7):e68401 [23844195.001]
  • [Cites] Science. 2014 Oct 31;346(6209):666 [25359978.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S87-91 [9988169.001]
  • [Cites] Emerg Infect Dis. 2016 Jul;22(7):1292-4 [27070504.001]
  • [Cites] Arch Virol Suppl. 1996;11:141-68 [8800796.001]
  • [Cites] J Bone Miner Res. 1994 Jun;9(6):951-60 [8079669.001]
  • [Cites] J Health Care Poor Underserved. 2007 May;18(2):331-40 [17483561.001]
  • [Cites] Arch Virol. 2010 Dec;155(12):2083-103 [21046175.001]
  • (PMID = 28505171.001).
  • [ISSN] 1935-2735
  • [Journal-full-title] PLoS neglected tropical diseases
  • [ISO-abbreviation] PLoS Negl Trop Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Posen HJ, Keystone JS, Gubbay JB, Morris SK: Epidemiology of Zika virus, 1947-2007. BMJ Glob Health; 2016 Aug;1(2):e000087

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of Zika virus, 1947-2007.
  • Considering 6 decades have passed since the first identification of the virus, it is perhaps unexpected that Zika virus was recognised only recently as capable of causing disease epidemics.
  • Substantial work on understanding the epidemiology of Zika virus has been conducted since the virus' first outbreak in 2007 in Micronesia; however, there has been little study of the earlier data on Zika virus.
  • METHODS: A systematic literature search was conducted to identify evidence of Zika virus infection in humans from 1947 to 2007.
  • RESULTS: 12 026 citations were retrieved by the literature search, and 76 articles were included in this review.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bull Soc Pathol Exot Filiales. 1988;81(1):58-70 [2900082.001]
  • [Cites] Am J Trop Med Hyg. 1958 May;7(3):323-8 [13533740.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1968 Nov-Dec;61(6):803-33 [5757302.001]
  • [Cites] Bull Soc Pathol Exot. 1993;86(1):21-8 [8099299.001]
  • [Cites] Prog Med Virol. 1968;10:415-86 [4886890.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20 [12995440.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1959 Mar;53(2):202-12 [13647627.001]
  • [Cites] Bull World Health Organ. 1970;42(5):797-805 [5311064.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1978 Mar-Apr;71(2):131-40 [33772.001]
  • [Cites] Am J Trop Med Hyg. 1975 May;24(3):516-20 [1174019.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1965 Sep-Oct;58(5):820-33 [5899554.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1963 Sep;57:364-71 [14062273.001]
  • [Cites] Bull World Health Organ. 1987;65(6):855-60 [3501739.001]
  • [Cites] Bull World Health Organ. 1967;36(1):113-50 [20604317.001]
  • [Cites] Ann Trop Med Parasitol. 1975 Mar;69(1):49-64 [1124969.001]
  • [Cites] J Trop Med Hyg. 1981 Apr;84(2):63-6 [7218404.001]
  • [Cites] Clin Microbiol Rev. 2016 Jul;29(3):487-524 [27029595.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1977 Mar-Apr;70(2):131-7 [579613.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1952 Sep;46(5):521-34 [12995441.001]
  • [Cites] Lancet. 1982 Dec 11;2(8311):1306-8 [6128599.001]
  • [Cites] Bull World Health Organ. 1968;38(2):229-37 [5302299.001]
  • [Cites] Zentralbl Bakteriol Orig A. 1973 Dec;225(2):375-80 [4150072.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1965 Sep;59(5):563-70 [5893149.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):237-40 [8758061.001]
  • [Cites] Lancet. 2016 Feb 20;387(10020):719-21 [26876373.001]
  • [Cites] Ann Soc Belg Med Trop. 1988 Mar;68(1):43-52 [3178324.001]
  • [Cites] J Immunol. 1952 Aug;69(2):223-34 [14946416.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1964 Jul;58:335-8 [14175744.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1974 Mar-Apr;67(2):126-40 [4480519.001]
  • [Cites] J Immunol. 1954 Apr;72(4):248-57 [13163397.001]
  • [Cites] J Clin Microbiol. 2016 Apr;54(4):860-7 [26888897.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1953 Jan;47(1):13-48 [13077697.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1982 May-Jul;75(3):262-6 [6809352.001]
  • [Cites] Am J Trop Med Hyg. 1977 Jul;26(4):792-7 [889019.001]
  • [Cites] Emerg Infect Dis. 2016 Jul;22(7):1185-92 [27070380.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1978 Mar-Apr;71(2):140-6 [743766.001]
  • [Cites] Bull World Health Organ. 1973;49(3):235-44 [4546521.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1979 Sep-Dec;72(5-6):416-23 [233526.001]
  • [Cites] Bull Soc Pathol Exot. 2001 Aug;94(3):227-30 [11681215.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1968 Nov-Dec;61(6):833-45 [4313384.001]
  • [Cites] Ann Trop Med Parasitol. 1983 Apr;77(2):131-7 [6309104.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1981;75(3):389-93 [6275577.001]
  • [Cites] Trop Geogr Med. 1986 Sep;38(3):203-8 [3018970.001]
  • [Cites] Am J Trop Med Hyg. 1954 Jan;3(1):9-18 [13114587.001]
  • [Cites] J Hyg Epidemiol Microbiol Immunol. 1978;22(2):184-9 [570581.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1956 Sep;50(5):442-8 [13380987.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1983;77(2):149-51 [6306872.001]
  • [Cites] J Autoimmun. 2016 Apr;68:1-13 [26925496.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1979;73(5):594-6 [531915.001]
  • [Cites] Bull World Health Organ. 1972;47(3):295-304 [4405506.001]
  • [Cites] Bull World Health Organ. 1968;38(6):843-54 [5303660.001]
  • [Cites] Ann Intern Med. 2009 Aug 18;151(4):264-9, W64 [19622511.001]
  • [Cites] N Engl J Med. 2016 Apr 21;374(16):1552-63 [27028561.001]
  • [Cites] Bull World Health Organ. 1967;37(3):343-61 [5301379.001]
  • [Cites] J Med Virol. 1989 Oct;29(2):79-81 [2600591.001]
  • [Cites] Am J Public Health. 2016 Apr;106(4):606-12 [26959260.001]
  • [Cites] Elife. 2015 Jun 30;4:e08347 [26126267.001]
  • [Cites] Bull World Health Organ. 1970;43(4):539-52 [5313066.001]
  • [Cites] Am J Trop Med Hyg. 2001 May-Jun;64(5-6):310-6 [11463123.001]
  • [Cites] Med Trop (Mars). 1980 Sep-Oct;40(5):561-8 [7442514.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1965 Jan-Feb;58(1):34-47 [5898053.001]
  • [Cites] J Gen Virol. 1974 Apr;23(1):91-6 [4833603.001]
  • [Cites] Bull World Health Organ. 1967;37(1):101-8 [5300043.001]
  • [Cites] Bull World Health Organ. 2016 Sep 1;94(9):675-686C [27708473.001]
  • [Cites] Rev Esp Salud Publica. 1998 May-Jun;72(3):245-50 [9810831.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1971 Jul-Aug;64(4):434-46 [4335761.001]
  • [Cites] Bull World Health Organ. 1966;34(1):105-11 [5295556.001]
  • [Cites] J Hyg (Lond). 1979 Oct;83(2):213-9 [489960.001]
  • [Cites] N Engl J Med. 2016 Feb 18;374(7):601-4 [26761185.001]
  • [Cites] Bull World Health Organ. 1970;43(2):223-67 [5312522.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1983;77(4):442-5 [6314612.001]
  • [Cites] Med Mal Infect. 2014 Jul;44(7):302-7 [25001879.001]
  • [Cites] Med Trop (Mars). 1981 Jan-Feb;41(1):53-61 [6268925.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1963 May-Jun;56:384-402 [14081696.001]
  • [Cites] Euro Surveill. 2010 Mar 11;15(10):19509 [20403310.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):851-4 [2559514.001]
  • [Cites] Science. 2016 Apr 15;352(6283):345-9 [27013429.001]
  • [Cites] Emerg Infect Dis. 2009 Sep;15(9):1347-50 [19788800.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1981 Sep-Oct;74(5):490-9 [6274526.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1954 Mar;48(2):139-45 [13157159.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1987;80(2):155-61 [3038355.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1973;67(5):702-9 [4779116.001]
  • [Cites] Am J Hyg. 1954 Mar;59(2):157-63 [13138582.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1974;68(1):30-8 [4206529.001]
  • [Cites] Bull World Health Organ. 1972;46(5):645-51 [4538037.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1965 Sep-Oct;58(5):812-20 [5899553.001]
  • [Cites] Trop Geogr Med. 1977 Jun;29(2):187-91 [906078.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1975 May-Jun;68(3):249-58 [1243735.001]
  • [Cites] Bull Soc Pathol Exot Filiales. 1954;47(2):223-7 [13182499.001]
  • [Cites] N Engl J Med. 2009 Jun 11;360(24):2536-43 [19516034.001]
  • (PMID = 28588942.001).
  • [Journal-full-title] BMJ global health
  • [ISO-abbreviation] BMJ Glob Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


8. He J, Xie Y, Kong S, Qiu W, Wang X, Wang D, Sun X, Sun D: Psychomotor retardation with a 1q42.11-q42.12 deletion. Hereditas; 2017;154:6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Psychomotor retardation with a 1q42.11-q42.12 deletion.
  • A 1q42 deletion is a rare structure variation that commonly harbours various deletion breakpoints along with diversified phenotypes.
  • A 1.9 Mb deletion located within 1q42.11-q42.12 was validated at the molecular cytogenetic level.
  • This is the first report of a 1q42.11-q42.12 deletion in a patient with onlypsychomotor retardation.

  • MedlinePlus Health Information. consumer health - Developmental Disabilities.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Med Genet A. 2015 Jun;167(6):1418-20 [25900767.001]
  • [Cites] Am J Med Genet A. 2010 Oct;152A(10):2493-504 [20799323.001]
  • [Cites] Nat Genet. 2007 Jun;39(6):721-3 [17529978.001]
  • [Cites] Clin Genet. 2010 Apr;77(4):404-7 [20095987.001]
  • [Cites] Am J Med Genet A. 2013 Aug;161A(8):2066-73 [23824842.001]
  • [Cites] Genet Med. 2007 Sep;9(9):607-16 [17873649.001]
  • [Cites] Br J Psychiatry. 1976 Dec;129:592-7 [1000144.001]
  • [Cites] RNA. 2010 May;16(5):969-79 [20348448.001]
  • [Cites] Eur J Med Genet. 2013 Jun;56(6):309-13 [23542665.001]
  • [Cites] Eur Neuropsychopharmacol. 2014 Oct;24(10):1630-40 [25129432.001]
  • [Cites] Am J Med Genet A. 2014 Feb;164A(2):441-8 [24357076.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:7-13 [25891250.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5712-23 [15469983.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5561-70 [15994928.001]
  • [Cites] J Biol Chem. 1994 Apr 15;269(15):11312-7 [8157663.001]
  • [Cites] Science. 2005 Mar 4;307(5714):1434-40 [15637236.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):395-409 [21044654.001]
  • [Cites] Am J Med Genet A. 2006 Aug 1;140(15):1637-43 [16835927.001]
  • [Cites] Neuroscience. 2009 Oct 6;163(2):646-61 [19540314.001]
  • [Cites] Hum Mutat. 2008 Sep;29(9):1118-24 [18570184.001]
  • [Cites] J Proteome Res. 2008 Jul;7(7):2959-72 [18549262.001]
  • [Cites] Biochem Biophys Res Commun. 2015 Aug 28;464(3):780-6 [26166824.001]
  • [Cites] J Cell Sci. 2016 Jan 1;129(1):51-64 [26604221.001]
  • [Cites] Am J Med Genet A. 2006 Jan 1;140(1):17-23 [16333846.001]
  • [Cites] Biochem J. 1974 Apr;139(1):77-88 [4463951.001]
  • [Cites] Am J Psychiatry. 2001 Feb;158(2):314-6 [11156819.001]
  • [Cites] J Med Genet. 2010 Jun;47(6):361-70 [20522425.001]
  • [Cites] J Affect Disord. 1995 Dec 13;35(3):107-15 [8749838.001]
  • [Cites] CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61 [14767398.001]
  • [Cites] Eur J Hum Genet. 2006 Sep;14(9):999-1008 [16736036.001]
  • [Cites] Nucleus. 2010 Mar-Apr;1(2):179-89 [21326950.001]
  • [Cites] Am J Psychiatry. 2005 Jun;162(6):1066 [15930053.001]
  • [Cites] Annu Rev Genomics Hum Genet. 2009;10:451-81 [19715442.001]
  • [Cites] Genomics. 1998 Dec 15;54(3):469-76 [9878250.001]
  • [Cites] EMBO Mol Med. 2013 Jul;5(7):1067-86 [23776131.001]
  • [Cites] Eur J Neurosci. 2006 Apr;23(8):2027-34 [16630050.001]
  • [Cites] Am J Med Genet A. 2010 Apr;152A(4):987-93 [20358614.001]
  • [Cites] J Affect Disord. 2004 Dec;83(2-3):109-20 [15555703.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Aug 4;346(3):1075-82 [16782053.001]
  • [Cites] Psychol Med. 2000 May;30(3):565-70 [10883712.001]
  • (PMID = 28286461.001).
  • [ISSN] 1601-5223
  • [Journal-full-title] Hereditas
  • [ISO-abbreviation] Hereditas
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; 1q42 deletion (major topic) / Genotype-phenotype correlation (major topic) / Microarray analysis (major topic) / Psychomotor retardation (major topic)
  •  go-up   go-down


9. Voskoboinik A, Kalman ES, Savicky Y, Sparks PB, Morton JB, Lee G, Kistler PM, Kalman JM: Reduction in radiation dose for atrial fibrillation ablation over time: A 12-year single-center experience of 2344 patients. Heart Rhythm; 2017 Jun;14(6):810-816
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduction in radiation dose for atrial fibrillation ablation over time: A 12-year single-center experience of 2344 patients.
  • OBJECTIVE: The purpose of this study was to analyze trends in radiation exposure for AF ablation over the last 12 years at our center.
  • Fluoroscopy time, and absorbed and effective doses significantly and progressively decreased over the 12-year period for initial PVI as follows: 2004-2006: 61 ± 27 minutes; 2007-2009: 46 ± 14 minutes, 1365 ± 1369 mGy, 11.3 ± 12.5 mSv; 2010-2012: 31 ± 11, 464 ± 339 mGy, 9.0 ± 10.4 mSv; and 2013-2015: 17 ± 9 minutes, 304 ± 758 mGy, 5.5 ± 6.7 mSv.
  • CF-sensing catheters were used for 357/508 PVI only cases between 2014 and 2015.
  • Fluoroscopy times (11 ± 5 vs 21 ± 8 minutes; P <.001) and absorbed dose (200 ± 524 vs 470 ± 1326 mGy; P = .004) were significantly shorter with this catheter.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28215568.001).
  • [ISSN] 1556-3871
  • [Journal-full-title] Heart rhythm
  • [ISO-abbreviation] Heart Rhythm
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Ablation / Atrial fibrillation / Contact force / Fluoroscopy / Radiation
  •  go-up   go-down


10. Marquez B, Murillo R: Racial/Ethnic Differences in Weight-Loss Strategies among US Adults: National Health and Nutrition Examination Survey 2007-2012. J Acad Nutr Diet; 2017 Jun;117(6):923-928
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Racial/Ethnic Differences in Weight-Loss Strategies among US Adults: National Health and Nutrition Examination Survey 2007-2012.
  • DESIGN: Cross-sectional data from the 2007-2012 National Health and Nutrition Examination Survey were used.
  • Models controlled for age, sex, education, and body mass index.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.
  • [Cites] J Acad Nutr Diet. 2014 Oct;114(10):1557-68 [25257365.001]
  • [Cites] J Community Health. 2015 Jun;40(3):542-8 [25394404.001]
  • [Cites] Prev Med. 2009 Aug-Sep;49(2-3):158-64 [19615401.001]
  • [Cites] Int J Behav Nutr Phys Act. 2011 Mar 22;8:20 [21426567.001]
  • [Cites] Obesity (Silver Spring). 2009 Apr;17(4):790-5 [19148119.001]
  • [Cites] Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38 [24222017.001]
  • [Cites] Obes Rev. 2014 Oct;15 Suppl 4:46-61 [25196406.001]
  • [Cites] Prev Med. 2002 Oct;35(4):390-6 [12453717.001]
  • [Cites] Int J Obes (Lond). 2010 Nov;34(11):1644-54 [20479763.001]
  • [Cites] J Natl Med Assoc. 2009 Jan;101(1):62-70 [19245074.001]
  • [Cites] Obesity (Silver Spring). 2013 Nov;21(11):2396-404 [23687100.001]
  • [Cites] Obes Rev. 2009 May;10(3):313-23 [19175510.001]
  • [Cites] Obesity (Silver Spring). 2008 Jun;16(6):1413-20 [18421273.001]
  • [Cites] Obesity (Silver Spring). 2009 Apr;17(4):713-22 [19180071.001]
  • [Cites] Am J Prev Med. 2012 May;42(5):481-5 [22516488.001]
  • [Cites] Am J Prev Med. 2007 Jul;33(1):34-40 [17572309.001]
  • [Cites] Ann Fam Med. 2013 Jan-Feb;11(1):43-52 [23319505.001]
  • [Cites] Int J Behav Nutr Phys Act. 2006 Nov 12;3:40 [17096859.001]
  • [Cites] Int J Obes Relat Metab Disord. 2002 Sep;26(9):1205-10 [12187397.001]
  • [Cites] Am J Public Health. 2016 Feb;106(2):321-6 [26691113.001]
  • [Cites] Obes Res. 2005 Mar;13(3):596-607 [15833946.001]
  • [Cites] J Am Diet Assoc. 2009 Oct;109(10):1769-74 [19782177.001]
  • [Cites] Am J Prev Med. 2010 Oct;39(4):305-13 [20837280.001]
  • [Cites] Ann Intern Med. 2015 Sep 1;163(5):399 [26322706.001]
  • [Cites] Econ Hum Biol. 2014 Jul;14:79-91 [22483443.001]
  • [Cites] Prev Med. 2010 Jul;51(1):24-6 [20420850.001]
  • [Cites] Am J Prev Med. 2006 Jul;31(1):18-24 [16777538.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):469-78 [25950254.001]
  • [Cites] NCHS Data Brief. 2010 Apr;(36):1-8 [20423605.001]
  • [Cites] Am J Public Health. 1994 Nov;84(11):1821-4 [7977925.001]
  • [Cites] Obes Res. 2002 May;10(5):345-50 [12006633.001]
  • [Cites] J Womens Health (Larchmt). 2004 Nov;13(9):1019-32 [15665659.001]
  • [Cites] J Natl Med Assoc. 2010 Jun;102(6):469-75 [20575211.001]
  • [Cites] J Am Diet Assoc. 2010 Apr;110(4):535-42 [20338279.001]
  • [Cites] Ethn Dis. 2007 Spring;17(2):262-7 [17682356.001]
  • [Cites] JAMA. 2016 Jun 7;315(21):2284-91 [27272580.001]
  • [Cites] Prev Chronic Dis. 2016 Oct 06;13:E142 [27710763.001]
  • [Cites] Am J Health Promot. 2011 Jul-Aug;25(6):402-9 [21721967.001]
  • [Cites] J Gen Intern Med. 2014 Jan;29(1):68-75 [24048655.001]
  • [Cites] Obesity (Silver Spring). 2009 Nov;17(11):2110-3 [19390515.001]
  • [Cites] Prev Med Rep. 2016 Jun 30;4:296-302 [27486558.001]
  • (PMID = 28330732.001).
  • [ISSN] 2212-2672
  • [Journal-full-title] Journal of the Academy of Nutrition and Dietetics
  • [ISO-abbreviation] J Acad Nutr Diet
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / K01 HL130726
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; National Health and Nutrition Examination Survey (NHANES) / Racial/ethnic disparities / Trying to lose weight / Weight-loss strategies
  •  go-up   go-down